Contribution
EUPRAXIA PHARMACEUTICALS INC.
$243,000.00
EF 2015-16 · 2016-03-30
Résumé
To support a firm in the Research and development in the physical, engineering and life sciences (NAICS: 541710) with a research and development project
Ministère
Programme
—
Bénéficiaire
Emplacement
Victoria, British Columbia|Victoria, Colombie-Britannique, Canada
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
Award spanning more than one fiscal year.
Additional Information (French)
Octroi s'appliquant à plus d'un exercice.
Agreement Start Date
2016-03-30
Agreement Type
Contribution
Agreement Value
$243,000.00
Amendment Number
0
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Purpose
To support a firm in the Research and development in the physical, engineering and life sciences (NAICS: 541710) with a research and development project
Program Purpose (French)
Pour supporter une compagnie dans le secteur Recherche et développement en sciences physiques, en génie et en sciences de la vie (SCIAN: 541710) dans un projet de recherche et développment
Recipient City
Victoria, British Columbia|Victoria, Colombie-Britannique
Recipient Country
CA
Recipient Legal Name
EUPRAXIA PHARMACEUTICALS INC.
Reference Number
GC-2016-Q1-29346
